一小时口服葡萄糖耐量试验用于1型糖尿病的预测与诊断监测
本研究在糖尿病预防试验1型(DPT-1)654例和TrialNet Pathway to Prevention(TNPTP)4610例参与者中,比较基于1小时口服葡萄糖耐量试验(OGTT)数据构建的风险评分DPTRS60与基于2小时OGTT的DPTRS对1型糖尿病(T1D)的预测准确性。结果显示两者5年预测ROC曲线下面积相似,DPTRS60预测显著优于2小时血糖;1小时血糖低于180 mg/dL对下次6个月访视前发生T1D的阴性预测值、阳性预测值和特异度与标准2小时阈值低于140 mg/dL相似(均≥98.5%)。结论认为1小时OGTT可像2小时OGTT一样准确预测T1D,且下次访视前漏诊T1D的风险极小。
要点
- DPTRS60与DPTRS预测5年T1D的ROC曲线下面积相似:DPT-1为0.805和0.794,TNPTP为0.832和0.847。
- DPTRS60预测T1D显著优于2小时血糖(两个队列均P < .001)。
- 1小时血糖低于180 mg/dL对下次6个月访视前发生T1D的阴性预测值、阳性预测值和特异度与2小时血糖低于140 mg/dL相似(均≥98.5%)。
核心结论
- 1小时OGTT可像2小时OGTT一样准确预测T1D,且下次访视前漏诊T1D的风险极小。
研究设计与样本
- 在糖尿病预防试验1型(DPT-1)(n = 654)和TrialNet Pathway to Prevention(TNPTP)(n = 4610)参与者中,将DPTRS修改为基于1小时OGTT数据的风险评分DPTRS60,并使用ROC曲线下面积(ROCAUC)比较DPTRS60与DPTRS的预测准确性。
主要发现
- 基线后5年T1D预测的ROCAUC在DPTRS60与DPTRS之间相似:DPT-1为0.805和0.794,TNPTP为0.832和0.847。
- DPTRS60预测T1D显著优于2小时血糖(两个队列均P < .001)。
- 1小时血糖低于180 mg/dL对下次6个月访视前发生T1D的阴性预测值、阳性预测值和特异度与标准2小时阈值低于140 mg/dL相似(均≥98.5%)。
关键数值与推荐
- DPTRS60使用空腹C肽、1小时血糖和C肽、年龄和体重指数构建。
- 1小时血糖低于180 mg/dL对下次6个月访视前发生T1D的阴性预测值、阳性预测值和特异度与2小时血糖低于140 mg/dL相似(均≥98.5%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Once islet autoantibody-positive individuals are identified, predicting which individuals are at highest risk for type 1 diabetes (T1D) is important. A metabolic risk score derived from 2-hour oral glucose tolerance test (OGTT) data, the Diabetes Prevention Trial-Type 1 risk score (DPTRS), can accurately predict T1D. However, 2-hour OGTTs are time-consuming and costly. OBJECTIVE: We aimed to determine whether a risk score derived from 1-hour OGTT data can predict T1D as accurately as the DPTRS. Secondarily, we evaluated whether a 1-hour glucose value can be used for diagnostic surveillance. METHODS: The DPTRS was modified to derive a 1-hour OGTT risk score (DPTRS60) using fasting C-peptide, 1-hour glucose and C-peptide, age, and body mass index. Areas under receiver operating curves (ROCAUCs) were used to compare prediction accuracies of DPTRS60 with DPTRS in Diabetes Prevention Trial-Type 1 (DPT-1) (n = 654) and TrialNet Pathway to Prevention (TNPTP) (n = 4610) participants. Negative predictive values (NPV) for T1D diagnosis were derived for 1-hour glucose thresholds. RESULTS: ROCAUCs for T1D prediction 5 years from baseline were similar between DPTRS60 and DPTRS (DPT-1: 0.805 and 0.794; TNPTP: 0.832 and 0.847, respectively). DPTRS60 predicted T1D significantly better than 2-hour glucose (P < .001 in both cohorts). A 1-hour glucose of less than 180 mg/dL had a similar NPV, positive predictive value, and specificity for T1D development before the next 6-month visit as the standard 2-hour threshold of less than 140 mg/dL (both ≥ 98.5%). CONCLUSION: A 1-hour OGTT can predict T1D as accurately as a 2-hour OGTT with minimal risk of missing a T1D diagnosis before the next visit.
引用
- Simmons KM, Sosenko JM, Warnock M, et al. One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes. J Clin Endocrinol Metab. 2020. PMID: 32844178. doi:10.1210/clinem/dgaa592
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。